ProMIS Neurosciences (PMN) Return on Equity [ROE] (2022 - 2026)
ProMIS Neurosciences (PMN) posted Return on Equity [ROE] of -78.95% for Q2 2026, up 538.97 percentage points from -617.92% a year earlier and up 60.26 percentage points from the prior quarter.
Powered by 
Analysis
ProMIS Neurosciences (PMN) Return on Equity [ROE] (2022 - 2026) Analysis & Trends
For FY2025, ProMIS Neurosciences' Return on Equity [ROE] came in at -527.92%, down 361.65 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a three-year change of +569.50 percentage points (FY2022 to FY2025).
- In prior years, ProMIS Neurosciences' Return on Equity [ROE] was -166.27% in FY2024 (+1019.56 pp), -1185.83% in FY2023 (-88.41 pp) and -1097.42% in FY2022.
- The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] in data going back to Q1 2022.
- On a year-over-year basis, Return on Equity [ROE] increased in four of the last six quarters, with an average year-over-year change of +22.45 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -139.20% (Q1 2026), -1014.03% (Q4 2025) and -804.06% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | ProMIS Neurosciences | 84.30 Mn | -54.60 Mn | - | -78.95% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -78.95% |
| Mar 31, 2026 | -139.20% |
| Dec 31, 2025 | -1,014.03% |
| Sep 30, 2025 | -804.06% |
| Jun 30, 2025 | -617.92% |
| Mar 31, 2025 | -158.79% |
| Dec 31, 2024 | -142.28% |
| Sep 30, 2024 | -591.51% |
| Mar 31, 2024 | -687.66% |
| Dec 31, 2023 | -273.83% |
| Sep 30, 2022 | -532.98% |
| Jun 30, 2022 | -305.97% |
| Mar 31, 2022 | -260.14% |
API Access
ProMIS Neurosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PMN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PMN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PMN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();